Janus Henderson Group PLC
- SEC CIK
- 0001274173
- Latest filing
- May 18, 2026
TRDA holding history
Entrada Therapeutics, Inc. in every 13F filed by Janus Henderson Group PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TRDA overviewAll 13F holders of TRDAFull Q1 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −1,521,281−100.0% | Sold out | Holders |
| Q2 2025 | 1,521,281 | $10.2M | <0.1% | −600,373−28.3% | Reduced | Holders |
| Q1 2025 | 2,121,654 | $20.3M | <0.1% | +41,287+2.0% | Added | Holders |
| Q4 2024 | 2,080,367 | $36.0M | <0.1% | +368,908+21.6% | Added | Holders |
| Q3 2024 | 1,711,459 | $27.4M | <0.1% | +161,962+10.5% | Added | Holders |
| Q2 2024 | 1,549,497 | $22.1M | <0.1% | +1,549,497 | New | Holders |